Does Discordance Between Baseline Patient’s and Evaluator’s Global Assessment of Disease Activity Impact Retention and Remission Rates of a First TNF Inhibitor in Patients with Axial Spondyloarthritis?

Merete L Hetland, Prof Rheumatology, Denmark: "Does Discordance Between Baseline Patient’s and Evaluator’s Global Assessment of Disease Activity Impact Retention and Remission Rates of a First TNF Inhibitor in Patients with Axial Spondyloarthritis?"

 

 

Håll dig uppdaterad inom Reumatologi!
Missa inte nya webbsändningar eller videoreportage från möten och kongresser

Prenumerera på vårt Nyhetsbrev

 

Kort produktresumé

Enbrel (etanercept)  Inflectra (infliximab)  Xeljanz (tofacitinib)